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Abstract
How can we optimize the use of drugs against parasites to limit the evolution of drug resistance? This question has been
addressed by many theoretical studies focusing either on the mixing of various treatments, or their temporal alternation.
Here we consider a different treatment strategy where the use of the drug may vary in space to prevent the rise of drug-
resistance. We analyze epidemiological models where drug-resistant and drug-sensitive parasites compete in a one-
dimensional spatially heterogeneous environment. Two different parasite life-cycles are considered: (i) direct transmission
between hosts, and (ii) vector-borne transmission. In both cases we find a critical size of the treated area, under which the
drug-resistant strain cannot persist. This critical size depends on the basic reproductive ratios of each strain in each
environment, on the ranges of dispersal, and on the duration of an infection with drug-resistant parasites. We discuss
optimal treatment strategies that limit disease prevalence and the evolution of drug-resistance.
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Introduction
The widespread use of antimicrobial drugs during the 20
th
century greatly contributed to the increase in human life
expectancy [1]. Yet, the emergence and the spread of drug
resistant parasites erode the benefits associated with these
treatments [2]. We now face the challenge of ‘‘resistance
management’’, which consists in finding a treatment strategy that
most reduces the number of infections, while keeping drug-
resistance at a low frequency. We therefore have to use optimized
treatment policies [3].
The development and the analysis of mathematical models have
played a major role in our understanding of the evolutionary
dynamics of drug resistance. These epidemiological models
allowed to compare various treatment strategies such as different
treatment doses [4,5], the mixing of different drugs, or treatment
cycling [3,6]. However, most of these theoretical studies focused
on the evolution of resistance in a single isolated population. The
evolutionary dynamics of drug resistance in a spatially heteroge-
neous environment seems to have been largely overlooked in the
context of infectious diseases in humans. Yet, attempts have been
made to take into account some aspects of spatial heterogeneity
using spatially implicit models. In these models, the host
population is structured into different compartments experiencing
different treatment strategies [7–9]. The importance of migration
rates among different compartments was pointed out, but relied on
a simplified description of the spatial spread of parasites, with no
isolation by distance. Such a metapopulation framework [10] is
well suited to model the evolutionary dynamics of drug resistance
in networks of hospitals [9] but fails to capture situations with
spatially limited dispersal.
The issue of resistance management is however not restricted to
human infectious diseases. For example, drug-resistance decreases
treatments efficiency in livestock [11], compromises the control of
parasitic fungi and pests in conventional [12] and genetically
modified crops [13]. The impact of the spatial heterogeneity of the
environment has been studied in models of fungicide resistance
[14,15], but also in models of insecticide-resistance management
[16–19], with the concept of a ‘‘stable zone strategy’’ [18], where a
heterogeneous treatment lowers the density of pests, while
preventing the onset of resistance, provided the treated area is
below a critical width.
The underlying concept comes from population genetics studies
[20–24] on the persistence of an allele under spatially varying
selection. When the favorable zone is smaller than a critical size,
migration counteracts the effects of natural selection, and gene
swamping occurs [25]. In these analytical studies however, the
population parameters (including the carrying capacity) are
arbitrarily fixed (but may vary in space [24]). In an epidemiolog-
ical context, the total parasite density, evaluated via the total
density of infected hosts, is typically not constant. Thus, we extend
in this paper the concept of a critical treatment area to an
epidemiological setting. In particular, we focus on the interplay
between demography – the total density of parasites – and the
frequency of drug-resistance. We consider two kinds of disease
transmission: (i) by direct contact between infected and non-
infected individuals, and (ii) via dispersing vectors. Under these
different scenarios, we discuss optimal treatment strategies that
prevent or limit the evolution of drug-resistance in a linear
environment.
Results
Direct transmission model
We first study a parasite life-cycle with direct parasite
transmission between hosts. At time t, and at each point x in a
one-dimensional environment, the host population is divided into
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sensitive parasites (labeled WT, for wild-type, throughout the
paper), IWT x,t ðÞ , or drug resistant parasites (labeled R throughout
the paper), IR x,t ðÞ . The total density of infected individuals is thus
Ix ,t ðÞ ~IWT x,t ðÞ zIR x,t ðÞ , and the proportion, among all
infected individuals, of individuals infected by drug-resistant
parasites is px ,t ðÞ ~IR x,t ðÞ =Ix ,t ðÞ . The within-host parasite
dynamics is not explicitly modeled, and I and p will hereafter be
referred to as the total parasite density and the frequency of
resistant parasites, respectively.
The disease is transmitted locally by direct contact between an
infected and a susceptible individual, with a transmission
parameter b
j
i. The subscript i refers to the parasite type: i~WT
for drug-sensitive parasites and i~R for drug-resistant parasites;
the superscript j refers to the area type: j~T in the treated area,
and j~U in the untreated area. Note that no superscript j is
requiredfordrug-resistantparasites,sincetheyarenotaffectedbythe
treatment, see figure 1. Infected individuals recover at rate c
j
i ,w h i c h
corresponds to parasite clearance. Recovered individuals imme-
diately become susceptible to the disease again, as in classical
SIS models [26]. Finally, the total density of the host population
remains constant in space and time (Sx ,t ðÞ zIx ,t ðÞ ~N). This
assumption implies that models with frequency-dependent or
density-dependent selection both lead to the same results [27].
Note also that, even though the total host density N is held
constant, the prevalence of the infection, Ix ,t ðÞ =N, varies in space
and time.
The environment is linear, and divided into treated and
untreated areas, of width A and B, respectively. We focus on
simple spatial patterns of treatment: a pocket of treatment in an
infinite untreated region (A small compared to B, see figure 1b); or
a periodical zebra-like pattern of treated and untreated regions (A
and B of the same order of magnitude, see figure 1c). All infected
individuals are treated in the treated area (but our model can be
readily extended to allow for a partial treatment). The treatment
lowers the transmission of drug-sensitive parasites (b
T
WTƒb
U
WT),
and/or increases their clearance (cT
WT§cU
WT), while drug-resistant
parasites remain unaffected. The resistance allele induces a fitness
cost [28], so that drug-resistant parasites are selected for in the
treated area, but selected against in the untreated area. This can
be seen by comparing the basic reproductive ratios, R
i,j
0 , of the two
strains (i~WT or i~R) in the two different environments (j~U, for
untreated, j~T, for treated; see figure 1a, and equation (1) below).
The basic reproductive ratio R0 is a compound parameter in
epidemiology, defined as the total number of secondary cases due
to the introduction of a single infected individual in a susceptible
population [26,29,30]. In a well-mixed population, a disease will
spread only if R0 is above unity [31]; R0 is also used to compare
different parasites, and to predict pathogen evolution [32]. For
strain i in habitat j, we have:
R
i,j
0 ~Nb
j
i
.
c
j
i ð1Þ
As illustrated on figure 1a, the drug-resistant parasites have a
higher basic reproductive ratio than the drug-sensitive parasites in
the treated area (RR
0 wR
WT,T
0 ). By contrast, the drug-sensitive
Figure 1. Effects of spatial heterogeneity on the parasites. The
treated area is represented with a dark gray filling. Subfigure (a) shows
the effects of treatment on the basic reproductive ratios R0. Blue stands
for drug-sensitive and red for drug-resistant. The arrow (1) shows the
effect of treatment on the drug-sensitive parasites, and (2) the cost of
drug-resistance. Subfigures (b) and (c) show numerical resolutions of
the direct transmission model. In (b), the width of the untreated area, B,
is infinite; in (c), B is finite. In (b) and (c), the full black curve is
the prevalence of the disease at equilibrium, I=N, and the orange
curve is the cline of frequency p of individuals infected by the drug-
resistant strain, among all infected individuals. The dashed black
curve represents the equilibrium prevalence in the absence drug-
resistant parasites. Parameters: N~100, b
U
WT~0:03, bR~0:025,
b
T
WT~0:02, cU
WT~1, cR~1:25, cT
WT~1:5.
doi:10.1371/journal.pcbi.1000337.g001
Author Summary
The spread of drug-resistant parasites erodes the efficacy
of therapeutic treatments against many infectious diseases
and is a major threat of the 21st century. The evolution of
drug-resistance depends, among other things, on how the
treatments are administered at the population level.
‘‘Resistance management’’ consists of finding optimal
treatment strategies that both reduce the consequence
of an infection at the individual host level, and limit the
spread of drug-resistance in the pathogen population.
Several studies have focused on the effect of mixing
different treatments, or of alternating them in time. Here,
we analyze another strategy, where the use of the drug
varies spatially: there are places where no one receives any
treatment. We find that such a spatial heterogeneity can
totally prevent the rise of drug-resistance, provided that
the size of treated patches is below a critical threshold. The
range of parasite dispersal, the relative costs and benefits
of being drug-resistant compared to being drug-sensitive,
and the duration of an infection with drug-resistant
parasites are the main factors determining the value of
this threshold. Our analysis thus provides some general
guidance regarding the optimal spatial use of drugs to
prevent or limit the evolution of drug-resistance.
Evolution of Drug-Resistance in Space
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resistant ones in the untreated area (RR
0 vR
WT,U
0 ).
Both infected and uninfected hosts migrate. The distribution of
the distances of migration (i.e. the kernel of migration) of both
hosts is assumed to be symmetric (i.e. with mean 0) and with
variance s2. We use the classical diffusion approximation, and
higher moments of the distribution are therefore neglected [33].
The above assumptions results in a system a partial differential
equations for the density of people infected by the drug-sensitive
(IWT) and drug-resistant parasites (IR), which is presented in the
Materials and Methods section (see system 14). We derive from
that system the following dynamical equations for the epidemiol-
ogy (parasite density I) and the evolution (frequency of resistance
p) of the parasite population at the point x and time t (for
readability we drop the time and space dependence notation in I
and p):
LI
Lt
~rp ,x ðÞ I 1{
I
Kp ,x ðÞ
  
z
s2
2
L
2I
Lx2 ð2aÞ
Lp
Lt
~sI ,x ðÞ p 1{p ðÞ zs2 Lp
Lx
LlnI
Lx
z
s2
2
L
2p
Lx2 ð2bÞ
where r, s and K are (using j~U in the untreated area and j~T in
the treated area):
rp ,x ðÞ ~N 1{p ðÞ b
j
WTzpbR
hi
{ 1{p ðÞ c
j
WTzpcR
  
ð3Þ
Kp ,x ðÞ ~N{
1{p ðÞ c
j
WTzpcR
1{p ðÞ b
j
WTzpbR
ð4Þ
sI ,x ðÞ ~ N{I ðÞ bR{b
j
WT
  
{ cR{c
j
WT
  
ð5Þ
These variables can be interpreted as a frequency-dependent
population growth rate (r), frequency-dependent population
carrying capacity (K), and density-dependent selection coefficient
for drug-resistant parasites (s).
This formulation clarifies the feed-back of demography on
evolution (i.e. the selection s varies with the prevalence of the
infection I), and vice versa (i.e. the parasite population growth rate
r depends on the frequency of resistance p). Figures 1b and 1c
show examples for the spatial variation in prevalence (I=N) and in
the frequency of resistance (p) at equilibrium.
Following on earlier studies [22,23,34], we derived the exact
minimal size of the untreated area, Bc, for drug-sensitive parasites
to invade a drug-resistant parasite population (see Text S1). The
opposite case, namely the invasion condition for a drug-resistant
strain to invade a drug-sensitive population, is more complicated.
Indeed, while the drug-resistant parasites’ traits are constant in
space (as we assume that the treatment has no effect on them), the
drug-sensitive parasites’ transmission and recovery parameters
depend on the spatial location. As a result, the equilibrium density
of a parasite population fixed for the drug-sensitive type varies
across space, and we did not find an exact analytic expression for
this equilibrium density (but approximate solutions can be found
using perturbation solutions [35]). This prevents us from deriving
a general invasion condition for drug-resistance. Yet, we present
below this invasion condition for two extreme migration scenarios.
First, when the migration range is restricted to the nearest
neighbors (i.e. s is small compared to A and B), the density of the
drug-sensitive parasite population varies sharply between
the treated and untreated areas. We assume that R
WT,T
0 w1,
i.e. that the drug cannot totally eradicate the parasite in a well-
mixed population even when all individuals are treated (the results
with a more efficient treatment, such as R
WT,T
0 v1, are presented in
Text S1). The effect of the initial asymmetry in population size can be
approximated by t, the (untreated/treated) ratio of the equilibrium
p a r a s i t ed e n s i t i e si ne a c ha r e ai nt h ea b s e n c eo fm i g r a t i o n :
t~
1{1
 
R
WT,U
0
1{1
 
R
WT,T
0
ð6Þ
Let us define s and a,s ot h a ts (resp. {a2s) is the drug-resistant
parasite’s initial rate of increase in a wholly treated (resp. untreated)
well-mixed population fixed for the drug-sensitive parasite. Using
equation (5), and rearranging, we obtain:
s~
RR
0
R
WT,T
0
{1
 !
cR ð7aÞ
a~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
{
RR
0
R
WT,U
0
{1
RR
0
R
WT,T
0
{1
v u u u u t ð7bÞ
Using this notation, the critical width of the treated area, under which
the drug-resistant strain cannot invade when initially rare, reads:
Alocal
c ~
s
ﬃﬃﬃﬃﬃ
2s
p arctan t2atanh a
ﬃﬃ
s
p
ﬃﬃﬃ
2
p
s
B
"#  !
ð8Þ
which is similar to the result found in earlier population genetics
studies [24], in which t, s and a are fixed parameters values. In
contrast, our study allows demography to feed-back on evolution; the
population parameters (t, s, a) are interdependent and vary with the
underlying life-history traits (see equations (6) and (7)).
Equation (8) shows that the critical size Alocal
c is proportional to
the range of migration s: the further the hosts migrate, the more
difficult it is for the drug-resistant parasites to invade. A high
migration indeed reinforces gene swamping. This recalls a classical
result in island models, which is that migration might prevent the
maintenance of diversity [36–38]. Equation (7a) shows that the
direction of selection is determined by the basic reproductive ratios
R
i,j
0 of each strain in each environment. In other words, as in
classical well-mixed models (see equation (10) below), the basic
reproductive ratios summarize most of the heterogeneity in
selection pressures acting on the two parasite types. Yet, an
additional epidemiological parameter, the recovery rate from an
infection with drug-resistant parasites, cR, is required to determine
the invasion condition of the drug-resistant parasites. In a spatially
heterogeneous environment indeed, the fate of drug-resistant
parasites does not only depend on the direction of selection
(governed by the ratio of R0s), but also on the intensity of selection
in the two environments. The intensity of selection is inversely
proportional to the drug-resistant parasites generation time, 1=cR.
In contrast, when there is very long-range migration (high s
compared to A and B), the effects of treatment can be averaged
over the whole habitat and, consequently, the asymmetry in
Evolution of Drug-Resistance in Space
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neglected. A classical invasion analysis based on the calculation of
the basic reproductive ratios of the different parasites is used to
derive the critical area size:
Aglobal
c ~B
cU
WT
cT
WT
R
WT,U
0 {RR
0
RR
0 {R
WT,T
0
ð9Þ
Note that this critical size depends not only on the various basic
reproductive ratios (R0), but also on the ratio of the recovery rates
from an infection by the drug-sensitive strain, in the untreated
(cU
WT) and treated (cT
WT) areas.
Instead of treating every infected individual in a restricted area
corresponding to a proportion A= AzB ðÞ of the environment, we
can choose to treat everywhere the same proportion A= AzB ðÞ of
infected individuals. We refer to this strategy as a homogeneous
treatment. Under this homogeneous strategy, the critical A only
depends on the basic reproductive ratios:
Ahomo
c ~B
R
WT,U
0 {RR
0
RR
0 {R
WT,T
0
ð10Þ
Hence, if we assume that the treatment increases the recovery rate
(cT
WT§cU
WT), then Aglobal
c is smaller than Ahomo
c . At high migration,
drug-resistance therefore appears more easily with a heteroge-
neous treatment than with a homogeneous treatment.
Figure 2 combines the above analytical results in a reciprocal
invasion plot, together with the outcome of numerical integrations of
system (2). For a fixed set of epidemiological parameters, we explore
the possible outcomes of the system, depending on the scaled total
size of the environment AzB ðÞ =s and the proportion of the
population that receives treatment (A= AzB ðÞ ) (Figure S1 shows the
same results, but plotted in function of the scaled sizes of the
untreated (B=s)a n dt r e a t e d( A=s) areas). With our parameters,
three outcomes are possible at equilibrium: exclusion of the drug-
sensitive strain (zone (1) in figure 2), exclusion of the drug-resistant
strain (zone (2)), or coexistence of both strains (zone (3)). With other
parameters, a fourth situation is possible, corresponding to
evolutionnary bistabilities, where only one strain is maintained, its
type depending on the initial conditions (see Figure S2). Figure 2
confirms that BwBc is an exact invasion criterion for the drug-
sensitive strain, while AwAlocal
c and AwAglobal
c give good
approximations of the invasion criteria of the drug-resistant strain
for low and large migration ranges s, respectively.
Vector-borne transmission model
In the above section we focused on a scenario with parasite
transmission by direct contact among hosts. In the following we
consider a more complex parasite life cycle involving two different
host species. In particular, we focus on vector-borne transmission
such as in malaria, leshmaniosis, trypanosomiasis and many other
human infections (the model holds for any disease involving the
sequential infection of two different hosts, and can be readily
extended to other two-stage life-cycles, with air-borne or water-
borne transmission for instance). Hereafter, we call the first host
‘‘human’’, and the second host ‘‘vector’’. Both humans and vectors
can migrate, though at potentially different ranges (with parameters
sH andsV respectively);thehumansrecover(ordie)atrateci (i~WT
for the drug-sensitive strain, and i~R for the drug-resistant strain),
and the vectors disappear at rate ni. The total densities of humans
(NH) and vectors (NV) remain constant, but the prevalence of the
infection may vary. In order to determine the critical width of the
treated area, under which the drug-resistant parasites cannot invade,
we use a low-migration approximation as in the previous section.
The asymmetries in population sizes between untreated and treated
areas are measured by the ratios tH (H for humans) and tV (V for
vectors) (see Text S1 for their formulation).
We find two critical sizes AH
c and AV
c , depending on whether
the initial density is calculated in the human (tH) or vector (tV)
compartments. Simulations show that these two critical sizes
closely bound the real critical size (see figure 3b). With k~H or
k~V, these bounding critical sizes read:
Ak
c~
se ﬃﬃﬃﬃﬃ
2s
p arctan t2
k atanh a
ﬃﬃ
s
p
ﬃﬃﬃ
2
p
s
B
"#  !
ð11Þ
The equivalent migration range se depends on the humans’ and
vectors’ migration ranges, but also on the duration of the infection
in both humans and vectors, and reads:
s2
e~
s2
V
 
nRzs2
H
 
cR
1=nRz1=cR
ð12Þ
Figure 2. This Reciprocal Invasion Plot represents the outcome
of the competition between drug-resistant and drug-sensitive
parasites (direct transmission model). This outcome depends on
the total size of the environment scaled by the migration range
parameter AzB ðÞ =s, and on the proportion of the treated area
A= AzB ðÞ . The curves show the analytical predictions, and the surfaces
result from numerical integrations. The curves delimit regions in the
parameter space where a parasite type can invade a population fixed
for the other type. Both types coexist when each type can invade the
other (i.e. when there is reciprocal invasion). The dashed red curve is
obtained from the critical size Aglobal
c (see equation (9)); the full red
curve corresponds to Alocal
c (see equation (8)), the full blue curve is
obtained from Bc (see Text S1), and finally the dashed gray curve comes
from Ahomo
c , corresponding to a spatially homogeneous treatment (see
equation (10)). In the red zone (1), only the drug-resistant strain persists
at equilibrium; in the blue zone (2), only the drug-sensitive strain
persists; in the gray zone (3) both strains coexist at equilibrium.
Parameters: N~100, b
U
WT~0:06, bR~0:055, b
T
WT~0:05, cU
WT~1,
cR~1:25, cT
WT~1:5.
doi:10.1371/journal.pcbi.1000337.g002
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intensity of selection for the drug-resistant parasite in a well-mixed
wholly treated (resp. untreated) population fixed for the drug-
sensitive strain. After rearranging, we obtain:
s&
RR
0
R
WT,T
0
{1
 !
1
1=cRz1=nR
ð13aÞ
a&
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
{
RR
0
R
WT,T
0
{1
RR
0
R
WT,U
0
{1
v u u u u t ð13bÞ
(see Text S1 for the whole expression for the basic reproductive
ratios R
i,j
0 ).
As in the single-host life cycle, the fate of drug-resistant parasites
depends on the intensities of selection in treated (s) and untreated
({a2s) areas. We thus recover very similar expressions for the
intensity of selection (compare equations (7) and (13)), which
depend on the ratios of R0 s and on the generation time of the
drug-resistant strain, which is 1=cRz1=nR in the two-host model.
The drug-sensitive invasion condition, Bc, is presented in Text
S1. The homogeneous invasion condition (see equation (10)) holds,
provided that the basic reproductive ratios are modified according
to the new life-cycle.
Discussion
In this study, we analyze the interplay between epidemiological
and evolutionary dynamics of a drug-resistant parasite strain in a
one-dimensional environment. Following on and extending earlier
population genetics studies on clines [22–24], we derive approx-
imations of invasion conditions for drug-resistant and drug-
sensitive strains, and for different modes of parasite transmission
(by direct contact, or vector-borne). In particular, we derive a
critical treatment area size below which a drug-resistant strain
cannot invade a population fixed for the drug-sensitive strain.
Under the critical treatment size, the effects of gene flow (i.e. the
immigration of drug-sensitive parasites from untreated areas, into
the treated) are stronger than the effects of natural selection (which
favors the drug-resistant strain in the treated area). Understanding
the factors that govern the value of these critical treatment areas
has direct practical implications: in particular, it may allow one to
optimize the use of antimicrobial drugs to prevent the emergence
and spread of drug-resistant pathogens. Furthermore, in the
broader context of insecticide-resistance, fungicide-resistance, or
resistance to toxins in genetically modified crops, taking space into
account may help develop new resistance management strategies.
In our direct transmission model, as pointed out earlier by
Nagylaki [22,24] in a population genetics context, the critical size
of the favorable area is proportional to s, the standard deviation of
the distribution of the distances of migration (i.e. the standard
deviation of the migration kernel), which is thus a measure of the
migration range. More migration increases the critical size because
it counteracts the effect of natural selection in the treated area.
Second, as emphasized by Nagylaki [24], asymmetric densities
(summarized in the compound parameter t) generate asymmetric
gene flow that selectively favor the allele in the most populated
area. In Nagylaki’s study [24], t and the selection parameters s
and a are independent. In our study however, the population
parameters (s, a, t) depend on explicit individual life-history traits
(such as b
j
i, c
j
i) [39] (for the direct transmission model, see
equations (6), (7a) and (7b) for t, s, and a). Consequently, in
contrast to earlier population genetics studies [24], the effects due
to the asymmetry in population sizes between habitats (t) and to
the heterogeneity of selection pressures (s, {a2s) are intermingled.
In addition, t is always greater than unity. Our critical size is
therefore greater than when no epidemiological feedback on
evolution is considered (see Text S1 for a comparison between
models with or without demographical feedback). The initial
asymmetry in drug-sensitive parasites’ densities makes the drug-
resistant parasites’ invasion harder.
A third factor determining of the critical size is the intensity of
selection for the invading strain, in each environment (s and
{a2s). In a spatially homogeneous habitat, where the intensity of
treatment does not vary in space, the invasion conditions are
exclusively governed by the sign of s, which only depends on the
basic reproductive ratios, R0, of the different parasites in treated
and untreated areas (see Ahomo
c s expression in equation (10)). Yet,
in a spatially heterogeneous environment, where treatment varies
in space, in addition to its direction, the intensity of selection in both
areas is required. The intensity of selection is inversely
proportional to the total duration of an infection with the drug-
resistant strain (1=cR with the direct transmission model, and
1=cRz1=nR ðÞ with the vector-borne transmission). This explains
the impact of the drug-resistant infection duration on the critical
area size. As a result, for a given value of R0, the shorter the
duration of the infection (i.e. high bR and cR), the more likely is
the drug-resistant parasite’s invasion (which corresponds to a lower
critical A size, see equations (8) and (11)), because the hosts have
less time to leave the favorable area. Consequently, a parasite with
fast dynamics is better locally adapted that one with slower
dynamics.
The basic reproductive ratios are classically used in epidemi-
ological models to evaluate the costs of drug-resistance [40,41], as
we did in figure 1a. Here we show that it is critical to know which
life-history traits are affected in drug-resistant parasites. This point
has already been raised in models with temporally varying
environments [42,43]. Thus, both temporal [43] and spatial
heterogeneities have the potential to alter the conclusions of
models of well-mixed populations, because the direct correspon-
dence between R0 and the fitness of a parasite strain does not hold
anymore. A practical implication of our results is that accurate
predictions regarding the evolution of drug-resistance require
more information on the life history traits of the parasites which
contribute to the cost of drug resistance [44].
Resistance management
Our model can be used to explore new strategies of resistance
management. Yet, various criteria can be used to define an
optimal strategy [45,46], based on the short-term or long-term
minimization of parasite prevalence, or on the frequency of drug-
resistance at equilibrium or in a transitory phase. In our model, we
focus on the equilibrium (i.e. long-term) frequency of drug-
resistance across space. We define a good treatment strategy as a
strategy under which a maximum proportion of individuals can be
treated, but which best prevents or limits the emergence and
spread of drug-resistant parasites.
Suppose that only a limited stock of treatment is available: only
a part of the population can be treated. Two (extreme) strategies
are considered: treating everyone in a limited area of width A, the
total size of the environment being AzB (a strategy referred to as
heterogeneous treatment), or treating the same proportion
A= AzB ðÞ of individuals everywhere (homogeneous treatment).
In both strategies, the same overall number of individuals are
treated, and all of them receive the same dose of treatment. Note
Evolution of Drug-Resistance in Space
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perspective, but heterogeneous locally (and conversely for the
heterogeneous treatment). Our definition thus contrasts with the
terminology used by other authors (e.g. [6]). Which treatment
strategy best prevents the invasion of drug-resistant parasites? With
a homogeneous treatment, there is no coexistence at equilibrium,
and the population will either be fixed at equilibrium for drug-
sensitive parasites, or for drug-resistant parasites. With a
heterogeneous treatment, however, drug-sensitive and drug-
resistant parasites can coexist at equilibrium. We compare the
evolutionary outcomes obtained under the two treatment
strategies in figure 3, using our model of vector-borne transmis-
sion.
For our set of epidemiological parameters, when the migration
range is large (figure 3a), three different cases may be considered:
(1) when the proportion of treated individuals is low (on the left-
hand side of the white point in figure 3a), both strategies are
equivalent because drug resistance does not emerge; (2) when the
proportion of treated individuals is intermediate (between the
white and gray points), drug resistance emerges and spreads in the
heterogeneous treatment strategy but not in the homogeneous one;
(3) when the proportion of treated individuals is high (on the right-
hand side of the gray point, so that AwAhomo
c ), both treatment
strategies are equivalent since drug resistance spreads to the whole
population under both scenarios.
When migration is more local (figure 3b), drug-resistance still
appears for a smaller proportion of treated individuals with the
spatially heterogeneous treatment. However, when the proportion
of treatment is such that AwAhomo
c and BwBc (i.e. between the
gray and black points in figure 3b), drug-resistant parasites
dominate the whole environment with the homogeneous strategy,
while the heterogeneous strategy still limits the spread of drug-
resistance. This is because a spatially heterogeneous treatment
maintains refuges for drug-sensitive parasites.
There is thus a critical migration range, above which the
heterogeneous strategy may better limit the spread of drug-
resistance. This critical migration range can be visualized in
figure 2, at the interception point of the Ahomo
c and Bc curves.
To illustrate further this point, let us take the example of two
vector-borne diseases, malaria and trypanosomiasis. Even though
we give here the example of two human diseases, recall that our
models are general enough to be applicable to a wide range of
parasites and hosts, including other animals and plants, provided
the use of adequate parameters. Anopheles mosquitoes, malaria
vectors, are known to migrate at longer ranges [47] than tsetse flies
[48], which are responsible for the transmission of trypanosomi-
asis. Our model suggests that, because of the different migration
patterns of their vectors, the optimal treatment strategy – treating
everyone but not everywhere or treating everywhere but not
everyone – that would best limit the spread of drug-resistance
might differ between the two systems. It might be better to treat
homogeneously against malaria (see figure 3a), while for
trypanosomiasis the optimal strategy may depend on the available
number of treatment doses (see figure 3b). Undoubtedly, treating
only part of the population raises ethical questions. What appears
to be the best solution for the population as a whole might not
reveal immediately good for some individuals. As a result,
untreated individuals looking for treatment may actively move
towards treated areas, and may therefore mitigate the benefits of
an heterogeneous treatment. Another way of creating a spatially
heterogeneous environment for the parasite would be to use
different drugs in different areas. This strategy, however, may
select for multiple drug resistance (see [8] for a numerical
investigation). Whether a spatial mosaic with two drugs better
prevents the evolution of drug-resistance than a spatially
homogeneous mixture of drugs remains to be investigated.
Of course, more quantitative recommendations for minimizing
parasite prevalence and the evolution of drug-resistance would
require a fully parameterized model of these two systems, as well as
relaxing several simplifying assumptions. In particular, it would be
worth extending our model to dispersal in two spatial dimensions,
and taking diploidy and the effects of dominance into account.
Both extensions have already been studied in a population genetics
context by Nagylaki [22], who showed that the critical favorable
area size is bigger in a model with two spatial dimensions, because
the effect of migration is stronger [22]. Recessivity of the resistance
locus also increases the critical favorable area size [22]. The
analysis of these effects in models with a demographical feed-back
on evolution requires further investigation. In the context of
infectious diseases, it would also be interesting to study the
potential influence of multiple infection events, whereby an
already infected host can be infected by another strain: this would
add another level of competition between parasitic strains, namely
Figure 3. Comparison between homogeneous and heteroge-
neous treatments. This figure represents the frequency of drug-
resistance at equilibrium, as a function of the proportion of treated
individuals (r~A= AzB ðÞ ), for the homogeneous (green) and hetero-
geneous (red) treatment strategies, with the vector-borne transmission
model. The migration range is high in (a), and low in (b). The curves
result from numerical integrations of the model, and the vertical lines
show the analytical predictions; r Xc ½  means ‘‘proportion of treated
individuals corresponding to the critical size Xc’’. The red full curve
shows the (spatial) mean frequency of drug-resistance, while the
dashed red curve shows this frequency at the center of the treated area
(x~0). Parameters: NH~1, NV~10, bT
WT~5, bU
WT~5:1, bR~5:05,
b
T
WT~2, b
U
WT~2, bR~2, cT
WT~2:5, cU
WT~2, cR~2:25, nT
WT~10,
nU
WT~10, nR~10;i n( a )sH~
ﬃﬃﬃ
1
p
, sV~
ﬃﬃﬃ
1
p
;i n( b )sH~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃ
0:01
p
,
sV~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃ
0:01
p
.
doi:10.1371/journal.pcbi.1000337.g003
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way to model migration, especially in human populations, where
individuals belong to interaction groups like households, and can
be treated in specific locations like hospitals [9]. It would therefore
be interesting to model more realistically both the spatial
distribution of individuals (i.e. uneven distribution in space) as
well as their migration patterns (i.e. various migration kernels).
In this paper we bridge the gap between the epidemiology and
the population genetics of drug-resistance [49,50] to study the
interplay between demography and evolutionary dynamics in a
spatially structured environment. Taking into account this eco-
evolutionary feedback may help better predict and prevent the rise
and spread of drug or vaccine resistance in pathogen populations.
Materials and Methods
Epidemiological models in a spatially heterogeneous
environment
We study two models, corresponding to two types of parasite
transmission. The parasites are modeled as asexual and haploid. In
all models, the individuals are infected by one strain only at a time,
and this strain cannot be displaced by the other (there is no
coinfection or superinfection). No mutation is explicitly modeled:
we assume that the drug-resistant strain pre-exists the treatment,
and we study the outcome of competition with the resident strain.
We assume that the hosts total density is constant in space and
time. However, the total density of parasites varies.
We focus on simple spatial patterns of treatment: a pocket of
treatment in an infinite untreated region (A small compared to B,
see figure 1b); or a periodical zebra-like pattern of treated and
untreated regions (A and B on the same scale, see figure 1c). The
effect of treatment and the cost of resistance are represented in
figure 1a using composite parameters, the basic reproductive ratios
R0 (see the main text).
The migration is modeled using the diffusion approximation. We
assume that there is no directional preference (the mean of the
dispersal kernel is zero), and that the standard deviation of the
migration kernel is s (the higher this parameter, the further dispersers
go). Higher moments of the distribution are neglected. In the
following, we present the direct transmission model; the analysis of
the vector-borne transmission model is detailed in Text S1.
Direct-transmission model
In our model with direct transmission of the parasites, only the
hosts diffuse, independent of their infectious status; the parasites
move with infected hosts. The densities of each parasite strain
depend on time (t) and space (x). These changes can be written as
a system of reaction-diffusion equations with three terms each
(dropping the time and space dependency in IWT and IR for
readability):
LIWT
Lt
~b
U
WT gb x ðÞ IWT N{IWT{IR ðÞ
{cU
WT gc x ðÞ IWTz
s2
2
L
2IWT
Lx2
ð14aÞ
LIR
Lt
~bRIR N{IWT{IR ðÞ {cRIRz
s2
2
L
2IR
Lx2 ð14bÞ
with gb and gc step functions that model the effects of the
treatment, so that gb x ðÞ ~1 and gc x ðÞ ~1 in the untreated area,
and gb x ðÞ ~b
T
WT
 
b
U
WT and gc x ðÞ ~cT
WT
 
cU
WT in the treated area.
For each equation in system (14), the first term represents new
infections with strain i, where the transmission of the disease from
infected (Ii) to uninfected (N{
P
k Ik) individuals happens at rate
b
j
i. The second term is the recovery (or death) from the disease,
equivalent to parasite clearance, which happens at rate c
j
i. The last
term stands for the diffusive migration of the hosts, with a
migration range s, which is the standard deviation of the
migration kernel.
The boundary conditions are periodic and reflecting:
LIi=Lxjx~{ AzB ðÞ ~LIi=Lxjx~ AzB ðÞ ~0, i[ WT,R fg ð15Þ
It means that there is no net movement of individuals at the
boundaries. Either the boundary cannot be crossed (like in a cage
or on an island), or there is no net movement of individuals,
because immigration and emigration compensate.
Let I be the total density of infected individuals, and p the
proportion, among all infected individuals, of individuals infected
by drug-resistant parasites:
I~IWTzIR ð16aÞ
p~
IR
I
ð16bÞ
Using system (15), and with a little bit of algebra, we obtain the
partial differential equations describing the dynamics of I and p,
which are presented in the results section (see system (2)).
Critical size in the direct transmission model
Finding the critical size of the treated (resp. untreated) area
comes to studying the stability of the drug-resistant free (resp.
drug-sensitive free) equilibrium. The method for the stability
analysis with the direct transmission model, under the low
migration approximation, is similar to the one already described
in [34,51,52].
Numerical Solutions
The sets of Partial Differential Equations (PDEs) can be
numerically solved using the Method of Lines implemented in
Mathematica’s NDSolve function. For each set of parameters, two
simulations are run, with different initial conditions, corresponding
to the invasion of the drug-sensitive strain in an environment
dominated by the drug-resistant strain, and reciprocally. If there
are bistabilities, the ultimate outcomes of the two simulations are
different.
Supporting Information
Figure S1 Reciprocal Invasion Plot. It is the same plot as in
figure 2 in the main text, but with different axes. Parameters:
N=100, bWT
U =0.06, bR=0.055, bWT
T =0.05, cWT
U =1,cR=1.25,
cWT
T =1.5
Found at: doi:10.1371/journal.pcbi.1000337.s002 (0.20 MB TIF)
Figure S2 Reciprocal Invasion Plot. The parameters are
different than in figure S1, and a fourth outcome is possible in
zone (4). It corresponds to a situation where, at equilibrium, only
one strain is maintained, but its type depends on the initial
conditions. Parameters: N=100, bWT
U =0.05, bR=0.08,
bWT
T =0.09, cWT
U =1,cR=2,cWT
T =2.5
Found at: doi:10.1371/journal.pcbi.1000337.s003 (0.20 MB TIF)
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